ADAM-17 over-expression in gallbladder carcinoma correlates with poor prognosis of patients

Medical Oncology

Volumn 28, Issue 2, 2011, Pages 475-480

  Wu, Kai ^a   Liao, Mingmei ^a   Liu, Bo ^b   Deng, Zhansheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ADAM 17; Clinicopathology; Gallbladder carcinoma; Prognosis

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 85027940360     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9481-8     Document Type: Article

References (21)

1. I Roa X De Aretxabala JC Araya J Roa 2006 Preneoplastic lesions in gallbladder cancer J Surg Oncol 93 615 623 16724345 10.1002/jso.20527 (Pubitemid 43855690)
2. JT Lewis JA Talwalkar CB Rosen TC Smyrk SC Abraham 2007 Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasiacarcinoma sequence Am J Surg Pathol 31 907 913 17527079 10.1097/01.pas.0000213435.99492.8a (Pubitemid 47165145)
3. S Misra A Chaturvedi NC Misra ID Sharma 2003 Carcinoma of the gallbladder Lancet Oncol 4 167 176 12623362 10.1016/S1470-2045(03)01021-0 (Pubitemid 36322307)
4. DR Edwards MM Handsley CJ Pennington 2008 The ADAM metalloproteinases Mol Aspects Med 29 258 289 18762209 10.1016/j.mam.2008.08.001 1:CAS:528: DC%2BD1cXht1ShsLnM
5. S Porter IM Clark L Kevorkian DR Edwards 2005 The ADAMTS metalloproteinases Biochem J 386 15 27 15554875 10.1042/BJ20040424 1:CAS:528:DC%2BD2MXhtFWmsbk%3D (Pubitemid 40289220)
6. M Borrell-Pages F Rojo J Albanell J Baselga J Arribas 2003 TACE is required for the activation of the EGFR by TGF-alpha in tumors EMBO J 22 1114 1124 12606576 10.1093/emboj/cdg111 1:CAS:528:DC%2BD3sXit1yls74%3D (Pubitemid 36313595)
7. C Brou F Logeat N Gupta, et al. 2000 A novel proteolytic cleavage involved in notch signaling: the role of the disintegrin-metalloprotease TACE Mol Cell 5 207 216 10882063 10.1016/S1097-2765(00)80417-7 1:CAS:528: DC%2BD3cXhslyht7s%3D (Pubitemid 30628080)
8. K Horiuchi HM Zhou K Kelly K Manova CP Blobel 2005 Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2 Dev Biol 283 459 471 15936750 10.1016/j.ydbio.2005.05.004 1:CAS:528:DC%2BD2MXmt1ejsLg%3D (Pubitemid 40977963)
9. PM McGowan BM Ryan AD Hill E Dermott NO Higgins MJ Duffy 2007 ADAM-17 expression in breast cancer correlates with variables of tumor progression Clin Cancer Res 13 2335 2343 17438092 10.1158/1078-0432.CCR-06-2092 1:CAS:528:DC%2BD2sXkt1enuro%3D (Pubitemid 46698582)
10. Y Takamune T Ikebe O Nagano, et al. 2007 ADAM-17 associated with CD44 cleavage and metastasis in oral squamous cell carcinoma Virchows Arch 450 169 177 17180679 10.1007/s00428-006-0350-y 1:CAS:528:DC%2BD2sXhslSqsLs%3D (Pubitemid 46295234)
11. YZ Fan JT Zhang HC Yang YQ Yang 2002 Expression of MMP-2, TIMP-2 protein and the ratio of MMP-2/TIMP-2 in gallbladder carcinoma and their significance World J Gastroenterol 8 1138 1143 12439941 1:CAS:528:DC%2BD38XpvVSnsLg%3D
12. HB Ma HT Hu ZL Di, et al. 2005 Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma World J Gastroenterol 11 744 747 15655836
13. ML Moss SL Jin ME Milla, et al. 1997 Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha Nature 385 733 736 9034191 10.1038/385733a0 1:CAS:528:DyaK2sXhsVGktbw%3D (Pubitemid 27098095)
14. AP Huovila AJ Turner M Pelto-Huikko I Karkkainen RM Ortiz 2005 Shedding light on ADAM metalloproteinases Trends Biochem Sci 30 413 422 15949939 10.1016/j.tibs.2005.05.006 1:CAS:528:DC%2BD2MXlvFaktLs%3D (Pubitemid 40942037)
15. J Zhao H Chen JJ Peschon, et al. 2001 Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis Dev Biol 232 204 218 11254358 10.1006/dbio.2001.0176 1:CAS:528:DC%2BD3MXhvFWgurg%3D (Pubitemid 32250955)
16. W Shi H Chen J Sun, et al. 2003 TACE is required for fetal murine cardiac development and modeling Dev Biol 261 371 380 14499647 10.1016/S0012-1606(03) 00315-4 1:CAS:528:DC%2BD3sXnt1ynurs%3D (Pubitemid 37108781)
17. Gooz M. ADAM-17: the enzyme that does it all. Crit Rev Biochem Mol Biol. 2010, in press.
18. F Blanchot-Jossic A Jarry D Masson, et al. 2005 Up-regulated expression of ADAM-17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells J Pathol 207 156 163 16041691 10.1002/path.1814 1:CAS:528:DC%2BD2MXhtFKnsr7J (Pubitemid 41404146)
19. Y Tanaka S Miyamoto SO Suzuki, et al. 2005 Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer Clin Cancer Res 11 4783 4792 16000575 10.1158/1078-0432.CCR-04-1426 1:CAS:528:DC%2BD2MXlvVGhu7w%3D (Pubitemid 41557199)
20. S Fabre-Lafay S Garrido-Urbani N Reymond A Goncalves P Dubreuil M Lopez 2005 Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-a-converting enzyme (TACE)/ADAM-17 J Biol Chem 280 19543 19550 15784625 10.1074/jbc.M410943200 1:CAS:528:DC%2BD2MXktFymtr4%3D (Pubitemid 41379475)
21. D Karan FC Lin M Bryan, et al. 2003 Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinoma Int J Oncol 23 1365 1371 14532978 1:CAS:528:DC%2BD3sXptFCrsr0%3D